SOCIETY OF SURGICAL ONCOLOGY
The Professional Home for Cancer Surgeons Worldwide
The Society of Surgical Oncology is a dynamic global community of cancer surgeons shaping advancements in the profession to deliver the highest quality surgical care for cancer patients. SSO promotes leading edge research, quality standards, and knowledge exchange connecting cancer surgeons worldwide to continuously improve cancer outcomes. Our highly regarded educational events and resources inspire members and spur each cancer surgeon to grow, improve, and thrive.
This is the promise we make to our members, supporters, partners, and representatives across the healthcare profession.
SSO 2019 Presidential Address
"Serendipity and Strategy on the Path of Progress"
In this video incoming SSO President Dr. David L. Bartlett (2019) introduces Dr. Armando Giuliano who delivers his Presidential Address titled, “Serendipity and Strategy on the Path of Progress.”
MY SSO COMMUNITY
Connect, collaborate and expand your network.
Find fellowship with peers from around the world in My SSO Community. Gain valuable insights, explore innovative ideas and share knowledge through candid, member-only conversations.
Marissa Howard-McNatt, MD, David Euhus, MD, Thuy Vu, MS, CGC, Brittany Puster
Surgical oncologists need to be educated about newly identified hereditary genetic mutations associated with an increased risk for breast cancer. A greater understanding of the risks associated with newly identified genetic mutations will help heighten awareness of the need to perform genetic testing to better select appropriate surgical interventions. This webinar is based on the SSO 2019 session.
You may find this activity in the Breast Disease section in the ExpertED@SSO catalog.
Faculty: Omid Hamid, MD, Genevieve Boland, MD, PhD, Mark Faries, MD and Charlotte Ariyan, MD
Learn about the mechanisms of action and toxicities of novel immunotherapeutic agents for metastatic melanoma and how to best integrate these agents with surgical options. Four specific topics will be covered including: systemic therapy, immune adjuvants for Stage IV melanoma, management of oligometastatic disease and surgical outcomes in melanoma in combination with immunotherapy.
You may find this activity in the Melanoma Disease section in the ExpertED@SSO catalog.
This activity is partially supported by independent educational grants from Amgen, Bristol Myers Squibb and Merck.
Save the date for SSO 2020. A completely new meeting experience awaits.
MARCH 25-28, 2020
This International Symposium will serve as a comprehensive forum to promote research, development and application.
FEBRUARY 15-17, 2020
Browse our database of other meetings available across the worldwide surgical oncology community.